Levels of Soluble Fas/Apo-1 in Patients With Behçet's Disease

Mediators of Inflammation - Egypt
doi 10.1080/09629359891261
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Hindawi Limited

Related search

Increased Endothelin-1 Levels of BAL Fluid in Patients With Behçet's Disease

Mediators of Inflammation
ImmunologyCell Biology
2007English

Fas/Apo-1(cd95) Expression and Apoptosis in Patients With Myelodysplastic Syndromes

Leukemia
Cancer ResearchOncologyAnesthesiologyPain MedicineHematology
1997English

Analysis of Serum Soluble Fas and Soluble Fas Ligand in Patients With Silicosis.

Sangyo eiseigaku zasshi = Journal of occupational health
MedicineEnvironmentalPublic HealthToxicologyOccupational Health
1998English

Soluble Fas Ligand and Soluble Fas in Ocular Fluid of Patients With Uveitis

British Journal of Ophthalmology
Molecular NeuroscienceOphthalmologySensory SystemsCellular
2000English

Levels of Soluble VCAM-1, Soluble ICAM-1, and Soluble E-Selectin in Patients With Tuberculous Pleuritis

Mediators of Inflammation
ImmunologyCell Biology
1996English

Correlation Between Serum Amyloid-A and Serum Levels of Proinflammatory Cytokines in Patients With Behçet's Disease

Pediatric Rheumatology
ImmunologyPediatricsRheumatologyAllergyPerinatologyChild Health
2015English

High Levels of Endothelial Progenitor Cells and Circulating Endothelial Cells in Patients With Behçet's Disease and Their Relationship to Disease Activity

Anais Brasileiros de Dermatologia
Dermatology
2019English

Behçet's Disease

Orphanet Journal of Rare Diseases
MedicineGeneticsPharmacology
2012English

Involvement of the CD95 (APO-1/Fas) Receptor/Ligand System in Multiple Sclerosis Brain

Journal of Experimental Medicine
MedicineAllergyImmunology
1996English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy